Health services provider UnitedHealth Group
What analysts say:
- Buy, sell, or waffle? Of the 21 analysts covering UnitedHealth, a heart-stopping 15 of them view the company as a buy. Only five say "hold," and one analyst -- apparently expecting a corporate coronary -- says "sell."
- Revenue. Revenue is expected to grow nearly 10% for the quarter, to $19.3 billion.
- Earnings. Profits, meanwhile, are anticipated to jump more than 12% to $0.71 per share.
What management says:
The health services juggernaut that is UnitedHealth Group rolls on. Its controversial bid to acquire Nevada-based Sierra Health Services
For its part, the services provider says Sierra Health is the "best-in-class" provider that will "significantly strengthen our growth platform in the region." It promises that physician penalties would be imposed "sparingly," and are only being implemented to save patients money, since out-of-network costs can run seven times higher than in-network services.
What management does:
There shouldn't be any shortfall in revenue at UnitedHealth, though margins might continue to get squeezed. That would help explain the company's recent moves to consolidate markets and keep doctors in line. However, with cuts anticipated in its Medicare Advantage program, UnitedHealth's longer-term profitability might be compromised.
12/05 |
03/06 |
06/06 |
09/06 |
12/06 |
|
---|---|---|---|---|---|
Gross |
27.5% |
26.5% |
25.9% |
25.5% |
25.5% |
Operating |
10.9% |
10.1% |
9.7% |
9.6% |
9.8% |
Net |
6.6% |
6.1% |
5.8% |
5.7% |
5.8% |
One Fool says:
Last summer's stock-option hullabaloo was merely a sideshow, though emblematic of a company that perhaps had enjoyed the laurels of its success too much. Yet it also created an opportunity for investors to buy at a discount a company that was otherwise a proven winner and realize substantial appreciation. It now trades again at some all-time highs, but is valued at a premium to competitors like Aetna
Related Foolishness:
UnitedHealth Group has earned a five-star rating from Motley Fool CAPS, the new investor-intelligence community. You can add your voice to the new stock-rating service by joining today. It's free!
UnitedHealth is a recommendation of both Motley Fool Stock Advisor and Motley Fool Inside Value. Lab Corp is a recommendation of Stock Advisor as well.
Fool contributor Rich Duprey does not own any of the stocks mentioned in this article. You can see his holdings here. The Motley Fool has a disclosure policy.